Ata ur Rehman Quraishi

ORCID: 0000-0003-0439-2251
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Heart Failure Treatment and Management
  • Coronary Interventions and Diagnostics
  • Erythropoietin and Anemia Treatment
  • Cardiac Arrest and Resuscitation
  • Blood transfusion and management
  • Aortic aneurysm repair treatments
  • Atrial Fibrillation Management and Outcomes
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Vascular Procedures and Complications
  • Clinical practice guidelines implementation
  • Acute Kidney Injury Research
  • Peripheral Artery Disease Management
  • Blood donation and transfusion practices
  • Analytical Methods in Pharmaceuticals
  • Stroke Rehabilitation and Recovery
  • Thyroid Disorders and Treatments
  • Emergency and Acute Care Studies
  • Cardiomyopathy and Myosin Studies
  • Neuroendocrine Tumor Research Advances
  • Mechanical Circulatory Support Devices
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Effects of Exercise
  • Long-Term Effects of COVID-19
  • Hemoglobinopathies and Related Disorders

Dalhousie University
2012-2022

Queen Elizabeth II Health Sciences Centre
2016-2022

Nova Scotia Health Authority
2022

Aga Khan University Hospital Nairobi
2005

<h3>Importance</h3> Among patients with ST-segment elevation myocardial infarction (STEMI) referred for primary percutaneous coronary intervention (PCI), a survival benefit associated radial access compared femoral remains controversial. <h3>Objective</h3> To assess whether there is when used instead of among STEMI PCI. <h3>Design, Setting, and Participants</h3> This multicenter, open-label, randomized clinical trial was conducted at 5 PCI centers in Canada. In total, 2292 were enrolled...

10.1001/jamacardio.2019.4852 article EN JAMA Cardiology 2020-01-02
Gerard Portela Jeffrey L. Carson Sonja A. Swanson John H. Alexander Paul C. Hébert and 95 more Shaun G. Goodman Philippe Gabríel Steg Marnie Bertolet Jordan B. Strom Dean Fergusson Tabassome Simon Harvey D. White Howard A. Cooper J. Dawn Abbott Sunil V. Rao Bernard R. Chaitman Christopher B. Fordyce Renato D. Lópes Benoit Daneault Maria M. Brooks Adam C. Salisbury Adam Gershon Adedayo Adeboye Adriana Carbonaro Adriano Caixeta A. Garvey Rene Agnes Y.Y. Lee Ahmad Mizyed Ahmed Hassanin A. Kone A. Cherian Akshay Bagai Alana Gulliver Aleisha Easton Alexandra Rousseau Alexandre Gautier Alexandre Schaan de Quadros Alexia Dantigny Alexia Ep Ali Ghamraoui Alice Jacobs Aline Giacomo Allison Schley Amanda Barnett Amanda Bollino Amanda Logan Amanda Salvatore Amanda Tice Amandine Grelier Amandine Ruissel Ameen Patel Ami Patel Amina Zamiti-Smondel Amy McMeans Andrea Sarafolean Andrew Baker Andrew M. Goldsweig Andrew P. DeFilippis Andrew Starovoytov Angeline Camilo Angélique Andrieu Angie Adler Anh-Phuong Pham Anna Helena Felipe Pereira Centurione Anna Koulova Anna S. Law Anna Tran Anne Druart Antoine Fayol Antoine Léquipar Anuritha Tirumani Anushka Jayasekara Araceli Boan Arav Jhand Ariel Diaz Arlete Matos Arnaud Ferrante Arthur Bracey Arthur Darmon Arthur Ramonatxo A. Aravind Asha Mellor Ashley Armstrong A. Adam Ata ur Rehman Quraishi Attílio Galhardo Audrey Cailliau Aurélie Gutehrle Axelle Fuentes Barbara Gallagher Barbara A. Konkle Barbara Shannon Barbara Shimada-Krouwer Barinder Hansra Barry H. Kaplan Barry F. Uretsky Basile Verdier Batric Popovic Baya Mahtout Behram Mody

The optimal hemoglobin threshold to guide red blood cell (RBC) transfusion for patients with acute myocardial infarction (MI) and anemia is uncertain. To estimate the efficacy of 4 individual thresholds (<10 g/dL [<100 g/L], <9 [<90 <8 [<80 <7 [<70 g/L]) in MI anemia. Prespecified secondary analysis MINT (Myocardial Ischemia Transfusion) trial using target emulation methods. (ClinicalTrials.gov: NCT02981407). 144 clinical sites 6 countries. 3492 participants a level below 10 g/dL. Four...

10.7326/m24-0571 article EN Annals of Internal Medicine 2024-09-30

Suppression of thyroid stimulating hormone (TSH) below the normal range with administration L-thyroxine has been shown to improve survival in patients treated for cancer (TC). Although most TC require long-term TSH suppression therapy, effect this treatment on cardiac rhythm remains unknown. A cross-sectional study was conducted determine prevalence atrial fibrillation (AF) suppressive therapy.All seen between June 2009 and March 2010 through a multidisciplinary oncology clinic, Halifax,...

10.25011/cim.v35i3.16591 article EN Clinical and investigative medicine 2012-06-01

Given changes in the care and outcomes of acute myocardial infarction (AMI) patients over past several decades, we sought to develop prediction models that could be used generate accurate risk-adjusted mortality readmission for hospitals current practice across Canada.A Canadian national expert panel was convened define appropriate AMI reporting models. Preliminary candidate variable evaluation conducted using Ontario hospitalized with a most responsible diagnosis from April 1, 2015 March...

10.1016/j.cjco.2021.04.012 article FR cc-by-nc-nd CJC Open 2021-05-01

To determine the one-year and five-year occurrence prognosticators of major adverse cardiac events (MACE: composition all-cause death, myocardial infarction, target vessel revascularization, thrombosis), mortality, lesion revascularization (TLR) in patients with in-stent restenosis (ISR) treated drug-eluting balloons (DEBs).DEBs have become an emerging therapeutic option for ISR. We report results a single-center retrospective study on treatment ISR DEB.94 consecutive paclitaxel-eluting...

10.1155/2022/1395980 article EN cc-by Journal of Interventional Cardiology 2022-08-29

The disposition of patients presenting with ST-elevation myocardial infarction (STEMI) is commonly the coronary care unit. Recent studies have suggested that low-risk STEMI could be managed in a lower-acuity setting immediately after percutaneous intervention (PCI). We sought to determine frequency downstream intensive-care therapy used our "stable" post-PCI.A single-centre, retrospective review was completed consecutive who underwent primary PCI for between 2013 and 2016. Post-PCI, were...

10.1016/j.cjco.2021.12.013 article FR cc-by CJC Open 2022-01-10
Coming Soon ...